These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3010671)

  • 1. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S; Whittle BJ
    Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
    [No Abstract]   [Full Text] [Related]  

  • 2. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
    Gorman RR; Wierenga W; Miller OV
    Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
    [No Abstract]   [Full Text] [Related]  

  • 3. A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Wright-Schulte Lecture.
    Verstraete M
    Haemostasis; 1982; 12(4):317-36. PubMed ID: 6295896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 5. Mode of action of dipyridamole on human platelets.
    Best LC; McGuire MB; Jones PB; Holland TK; Martin TJ; Preston FE; Segal DS; Russell RG
    Thromb Res; 1979; 16(3-4):367-79. PubMed ID: 229583
    [No Abstract]   [Full Text] [Related]  

  • 6. Lanthanum stimulates the accumulation of cyclic AMP and inhibits secretion and thromboxane B2 formation in human platelets.
    Best LC; Bone EA; Jones PB; Russell RG
    Biochim Biophys Acta; 1980 Oct; 632(2):336-42. PubMed ID: 6251913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 8. Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis.
    Heyns Adu P; Eldor A; Yarom R; Marx G
    Blood; 1985 Jul; 66(1):213-9. PubMed ID: 2988668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin prolongs viability of washed human platelets.
    Blackwell GJ; Radomski M; Vargas JR; Moncada S
    Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
    Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
    Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
    Miller OV; Ayer DE; Gorman RR
    Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is prostacyclin a physiologically important circulating anti-platelet agent?
    Steer ML; MacIntyre DE; Levine L; Salzman EW
    Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella.
    Vargaftig BB; Prado-Franceschi J; Chignard M; Lefort J; Marlas G
    Eur J Pharmacol; 1980 Dec; 68(4):451-64. PubMed ID: 7009169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
    Wilson AP; Efthimiou J; Betteridge DJ
    Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.